본문으로 건너뛰기
← 뒤로

Acute myeloid leukemia risk stratification in younger and older patients through transcriptomic machine learning models.

1/5 보강
Scientific reports 📖 저널 OA 96.3% 2021: 24/24 OA 2022: 32/32 OA 2023: 45/45 OA 2024: 140/140 OA 2025: 938/938 OA 2026: 698/767 OA 2021~2026 2025 Vol.15(1) p. 39821
Retraction 확인
출처

Silva R, Riedel C, Amico M, Reboul J, Guibert B, Sennaoui C, Bessiere C, Ruffle F, Gilbert N, Boureux A, Commes T

📝 환자 설명용 한 줄

Acute Myeloid Leukemia (AML) is a genetically and clinically heterogeneous disease that can develop at any age.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Silva R, Riedel C, et al. (2025). Acute myeloid leukemia risk stratification in younger and older patients through transcriptomic machine learning models.. Scientific reports, 15(1), 39821. https://doi.org/10.1038/s41598-025-23468-z
MLA Silva R, et al.. "Acute myeloid leukemia risk stratification in younger and older patients through transcriptomic machine learning models.." Scientific reports, vol. 15, no. 1, 2025, pp. 39821.
PMID 41233459 ↗

Abstract

Acute Myeloid Leukemia (AML) is a genetically and clinically heterogeneous disease that can develop at any age. While AML incidence increases with age and distinct genetic alterations are observed in younger versus older patients, current classification systems do not incorporate age as a defining factor. In this study, we analyzed RNA-seq data from 404 AML patients at initial diagnosis, leveraging a k-mer-based machine learning approach to uncover age-related transcriptomic differences in favorable and adverse risk groups. Our model achieved over 90% accuracy in risk prediction and identified key gene signatures distinguishing ELN2017 favorable and adverse groups. From these signatures, we selected prognostic biomarkers with significant impacts on survival. Additionally, we explored the biological context underlying transcriptomic complexity across age groups, revealing distinct tumor profiles and differences in immune and stromal cell populations, particularly in older patients. These findings underscore the importance of age-related molecular features in AML and provide new insights for risk stratification and therapeutic targeting.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

… 외 1개

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기